Menu
Live News EQUITY M impact

DFTX: Jones Trading Raises PT

Jones Trading analyst Justin Walsh maintains Definium Therapeutics with a Buy and raises the price target from $61 to $74

DFTX

Jones Trading analyst Justin Walsh maintains Definium Therapeutics (NASDAQ: DFTX ) with a Buy and raises the price target from $61 to $74.